Lung Cancer Prediction from Text Datasets Using Machine Learning

Lung cancer is the major cause of cancer-related death in this generation, and it is expected to remain so for the foreseeable future. It is feasible to treat lung cancer if the symptoms of the disease are detected early. It is possible to construct a sustainable prototype model for the treatment of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BioMed research international 2022, Vol.2022 (1), p.6254177-6254177
Hauptverfasser: Anil Kumar, C., Harish, S., Ravi, Prabha, SVN, Murthy, Kumar, B. P. Pradeep, Mohanavel, V., Alyami, Nouf M., Priya, S. Shanmuga, Asfaw, Amare Kebede
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Lung cancer is the major cause of cancer-related death in this generation, and it is expected to remain so for the foreseeable future. It is feasible to treat lung cancer if the symptoms of the disease are detected early. It is possible to construct a sustainable prototype model for the treatment of lung cancer using the current developments in computational intelligence without negatively impacting the environment. Because it will reduce the number of resources squandered as well as the amount of work necessary to complete manual tasks, it will save both time and money. To optimise the process of detection from the lung cancer dataset, a machine learning model based on support vector machines (SVMs) was used. Using an SVM classifier, lung cancer patients are classified based on their symptoms at the same time as the Python programming language is utilised to further the model implementation. The effectiveness of our SVM model was evaluated in terms of several different criteria. Several cancer datasets from the University of California, Irvine, library were utilised to evaluate the evaluated model. As a result of the favourable findings of this research, smart cities will be able to deliver better healthcare to their citizens. Patients with lung cancer can obtain real-time treatment in a cost-effective manner with the least amount of effort and latency from any location and at any time. The proposed model was compared with the existing SVM and SMOTE methods. The proposed method gets a 98.8% of accuracy rate when comparing the existing methods.
ISSN:2314-6133
2314-6141
DOI:10.1155/2022/6254177